| STRIDE: Structure-guided Generation for Inverse Design of Molecules | Nov 6, 2023 | Drug DesignDrug Discovery | —Unverified | 0 |
| Structural insights into characterizing binding sites in EGFR kinase mutants | Dec 27, 2018 | Drug Design | —Unverified | 0 |
| Structure-aware generation of drug-like molecules | Nov 7, 2021 | Drug Design | —Unverified | 0 |
| Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling | Feb 22, 2024 | Drug DesignMolecular Docking | —Unverified | 0 |
| Structure-based drug design with geometric deep learning | Oct 19, 2022 | Deep LearningDrug Design | —Unverified | 0 |
| Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | Jul 15, 2024 | Domain GeneralizationDrug Design | —Unverified | 0 |
| SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design | Jun 19, 2023 | Drug DesignIn-Context Learning | —Unverified | 0 |
| Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers | Dec 31, 2022 | Drug DesignDrug Discovery | —Unverified | 0 |
| SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Design | Oct 3, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Systems-Structure-Based Drug Design | Oct 14, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations | May 13, 2015 | Drug Design | —Unverified | 0 |
| CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models | Apr 2, 2020 | AttributeDrug Design | —Unverified | 0 |
| Template-Guided 3D Molecular Pose Generation via Flow Matching and Differentiable Optimization | May 22, 2025 | Drug DesignPose Prediction | —Unverified | 0 |
| GlycoNMR: Dataset and benchmarks for NMR chemical shift prediction of carbohydrates with graph neural networks | Nov 28, 2023 | Drug Designmolecular representation | —Unverified | 0 |
| tFold-TR: Combining Deep Learning Enhanced Hybrid Potential Energy for Template-Based Modeling Structure Refinement | May 10, 2021 | Drug DesignProtein Structure Prediction | —Unverified | 0 |
| The known unknowns of the Hsp90 chaperone | Aug 31, 2023 | Drug DesignKnown Unknowns | —Unverified | 0 |
| The recent advances in the mathematical modelling of human pluripotent stem cells | Sep 23, 2019 | Drug Design | —Unverified | 0 |
| The Structural Biology and Critical Evaluation of Bacterial Proteases as Targets in New Drug Design | Jun 3, 2014 | Drug DesignSpecificity | —Unverified | 0 |
| Token-Mol 1.0: Tokenized drug design with large language model | Jul 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Towards Efficient Molecular Property Optimization with Graph Energy Based Models | Feb 17, 2025 | Drug Design | —Unverified | 0 |
| Towards Interpretable Sparse Graph Representation Learning with Laplacian Pooling | May 28, 2019 | Drug DesignDrug Discovery | —Unverified | 0 |
| Hybrid quantum-classical machine learning for generative chemistry and drug design | Aug 26, 2021 | Drug DesignDrug Discovery | —Unverified | 0 |
| TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design | Mar 26, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Transfer Learning for Bayesian Optimization: A Survey | Feb 12, 2023 | Bayesian OptimizationDrug Design | —Unverified | 0 |
| Transformative Machine Learning | Nov 8, 2018 | BIG-bench Machine LearningDrug Design | —Unverified | 0 |
| Two for the Price of One: Integrating Large Language Models to Learn Biophysical Interactions | Mar 26, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Understanding of Genetic Code Degeneracy and New Way of Classifying of Protein Family: A Mathematical Approach | Nov 30, 2015 | Drug Design | —Unverified | 0 |
| Understanding Protein Dynamics with L1-Regularized Reversible Hidden Markov Models | May 6, 2014 | Distributed ComputingDrug Design | —Unverified | 0 |
| Unified Guidance for Geometry-Conditioned Molecular Generation | Jan 5, 2025 | Drug Design | —Unverified | 0 |
| Synergistic Benefits of Joint Molecule Generation and Property Prediction | Apr 23, 2025 | Drug Designmolecular representation | —Unverified | 0 |
| Unveiling the frontiers of deep learning: innovations shaping diverse domains | Sep 6, 2023 | Deep LearningDrug Design | —Unverified | 0 |
| Using Deep Reinforcement Learning to Generate Rationales for Molecules | Jan 1, 2018 | Deep Reinforcement LearningDrug Design | —Unverified | 0 |
| Using the structural kinome to systematize kinase drug discovery | Apr 27, 2021 | Drug DesignDrug Discovery | —Unverified | 0 |
| Vertex-Edge Weighted Molecular Graphs: A study on topological indices and their relevance to physicochemical properties of drugs in use cancer treatment | Jul 28, 2024 | Drug Design | —Unverified | 0 |
| Robust Graph Meta-learning for Weakly-supervised Few-shot Node Classification | Jun 12, 2021 | ClassificationDrug Design | —Unverified | 0 |
| Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model | Aug 14, 2022 | Drug DesignDrug Discovery | —Unverified | 0 |
| xTrimoABFold: De novo Antibody Structure Prediction without MSA | Nov 30, 2022 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Y-Mol: A Multiscale Biomedical Knowledge-Guided Large Language Model for Drug Development | Oct 15, 2024 | Drug DesignKnowledge Graphs | —Unverified | 0 |
| Multi-objective generative AI for designing novel brain-targeting small molecules | Apr 16, 2024 | Drug DesignGraph Neural Network | —Unverified | 0 |
| Navigating the Maize: Cyclic and conditional computational graphs for molecular simulation | Jan 22, 2024 | Active LearningComputational chemistry | —Unverified | 0 |
| New Candidates for Furin Inhibition as Probable Treat for COVID-19: Docking Output | Jul 27, 2021 | Drug Design | —Unverified | 0 |
| NLRP3 monomer Functional Dynamics: from the Effects of Allosteric Binding to Implications for Drug Design | Sep 7, 2023 | Drug Design | —Unverified | 0 |
| Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective | Mar 10, 2020 | Drug Design | —Unverified | 0 |
| One-way Explainability Isn't The Message | May 5, 2022 | Drug Design | —Unverified | 0 |
| Optimization of Tree Ensembles | May 30, 2017 | Drug Design | —Unverified | 0 |
| Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES | May 1, 2024 | Drug DesignEvolutionary Algorithms | —Unverified | 0 |
| Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks | May 4, 2023 | Active LearningDrug Design | —Unverified | 0 |
| Overview of Current Type I/II Kinase Inhibitors | Nov 23, 2018 | Drug DesignVocal Bursts Type Prediction | —Unverified | 0 |
| ParaVS: A Simple, Fast, Efficient and Flexible Graph Neural Network Framework for Structure-Based Virtual Screening | Feb 8, 2021 | Drug DesignGraph Neural Network | —Unverified | 0 |
| PepINVENT: Generative peptide design beyond the natural amino acids | Sep 21, 2024 | Drug Design | —Unverified | 0 |